Paramedic Papers

Home Obstetrics Low HDFN risk after prehospital RhD-positive blood

Obstetrics

Low HDFN risk after prehospital RhD-positive blood

Rate of future hemolytic disease of the fetus and newborn following the prehospital transfusion of RhD-positive blood products to females of childbearing potential in the United States of America
Prehospital Emergency Care · Added 1 September 2026

In silico simulation modelling future haemolytic disease of the fetus and newborn risk in 957 US females of childbearing potential who received prehospital RhD-positive blood — annual HDFN risk ranged 0.214–0.294% across regions

Study type
Modelling
Design
In silico simulation modelling
Participants
957 US females of childbearing potential transfused prehospital with RhD-positive products over ~5 years; 19.5 million simulated FCPs
Main finding
Annual future HDFN risk ranged 0.214% (Northeast) to 0.294% (South); 1,368 cases over the 2,500-year simulation (0.55/year), i.e. one case every ~2.4–80.7 years by region
Caveat
Modelled estimates reliant on assumptions about nativity, age distribution and future pregnancy rates
Bottom line
Supports current practice

Why it matters in Australia (Medium relevance). transferability — Not in the ACTAS formulary — blood products are not carried, but important safety consideration if ACTAS ever adopts prehospital blood

Learning goal

Weigh the future haemolytic disease risk when transfusing RhD-positive blood to females of childbearing potential prehospital.

Open in dashboard Read the paper (DOI) PubMed

More

Related papers on Obstetrics